Ahmedabad Civil Hospital performs free hip replacement on ITP patient
Synopsis
Key Takeaways
Ahmedabad Civil Hospital successfully performed a high-risk total hip replacement on Sangeeta Trivedi, a Uttar Pradesh resident living with Idiopathic Thrombocytopenic Purpura (ITP), a serious blood disorder that sharply elevates the risk of uncontrolled bleeding during surgery. The procedure, conducted free of cost at the government-run facility, was completed safely on 1 August, hospital officials confirmed.
Why This Case Was High-Risk
ITP causes a critically low platelet count, leaving patients highly vulnerable to severe bleeding during any surgical intervention, since platelets are essential to the body's clotting mechanism. According to Professor Dr Piyush Mittal of the Department of Orthopaedics, Trivedi had been living with ITP for an extended period.
Prolonged steroid therapy used to manage her ITP led to a secondary complication: Avascular Necrosis (AVN), which severely damaged her hip joint over time. As her condition deteriorated, a total hip replacement became the only clinically viable option to restore her mobility.
Why She Turned to a Government Hospital
Before arriving at Ahmedabad Civil Hospital, Trivedi had approached several private hospitals, where the estimated cost of the surgery ranged between ₹3 lakh and ₹5 lakh. Multiple private facilities reportedly declined or expressed serious reservations about proceeding, citing the life-threatening bleeding risk posed by her ITP.
She subsequently sought treatment at the government hospital, where doctors agreed to take on the case after a thorough evaluation.
Multidisciplinary Approach and Surgical Execution
Before proceeding, the hospital assembled a multidisciplinary team spanning the Departments of Orthopaedics, Haematology, Anaesthesia, and the Blood Bank. A comprehensive pre-operative assessment and coordinated treatment plan were put in place to manage the bleeding risk.
During the operation, Professor Dr Shakuntala and the anaesthesia team played a central role in stabilising the patient. To control bleeding, Trivedi received five units of platelets, one unit of Fresh Frozen Plasma (FFP), and one unit of Packed Cell Volume (PCV). The planned blood component support allowed the surgical team to complete the procedure safely.
Patient Condition and Hospital Response
Medical Superintendent Dr Rakesh Joshi said the outcome underscored what government hospitals are capable of delivering. 'The Department of Orthopaedics has successfully performed a Total Hip Replacement on a patient suffering from Idiopathic Thrombocytopenic Purpura. This achievement once again demonstrates that government hospitals are capable of delivering world-class, highly complex medical treatment successfully,' he said.
Hospital officials confirmed that Trivedi is in stable condition following the surgery. She has been relieved of severe hip pain and is now able to walk independently and carry out daily activities — a significant improvement after prolonged illness and restricted mobility.
The case is being cited by hospital administration as evidence that specialised, high-risk surgical care need not be the exclusive preserve of private healthcare. Whether it prompts broader policy attention to capacity-building at government tertiary centres remains to be seen.